# | Title | Journal | Year | Citations |
---|
1 | In-hospital mortality and morbidity of elderly medical patients can be predicted at admission by the Modified Early Warning Score: a prospective study | International Journal of Clinical Practice | 2009 | 670 |
2 | Characterising the castration-resistant prostate cancer population: a systematic review | International Journal of Clinical Practice | 2011 | 614 |
3 | Prevalence of hypogonadism in males aged at least 45 years: the HIM study | International Journal of Clinical Practice | 2008 | 601 |
4 | Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update | International Journal of Clinical Practice | 2012 | 446 |
5 | Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia | International Journal of Clinical Practice | 2006 | 400 |
6 | The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys | International Journal of Clinical Practice | 2007 | 393 |
7 | The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review | International Journal of Clinical Practice | 2008 | 387 |
8 | Health benefits of physical activity in older patients: a review | International Journal of Clinical Practice | 2009 | 374 |
9 | Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema | International Journal of Clinical Practice | 2006 | 369 |
10 | Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review | International Journal of Clinical Practice | 2009 | 366 |
11 | Assessment and characterisation of post‐COVID‐19 manifestations | International Journal of Clinical Practice | 2021 | 352 |
12 | The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases | International Journal of Clinical Practice | 2009 | 348 |
13 | Understanding heterogeneity in meta-analysis: the role of meta-regression | International Journal of Clinical Practice | 2009 | 323 |
14 | DPP-4 inhibitors and their potential role in the management of type 2 diabetes | International Journal of Clinical Practice | 2006 | 311 |
15 | Help-seeking behaviour for sexual problems: the Global Study of Sexual Attitudes and Behaviors | International Journal of Clinical Practice | 2005 | 296 |
16 | Neurobiology of depression: an integrated view of key findings | International Journal of Clinical Practice | 2007 | 292 |
17 | Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden | International Journal of Clinical Practice | 2007 | 284 |
18 | SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate | International Journal of Clinical Practice | 2020 | 283 |
19 | Communication in healthcare: a narrative review of the literature and practical recommendations | International Journal of Clinical Practice | 2015 | 282 |
20 | Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial | International Journal of Clinical Practice | 2013 | 281 |
21 | Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial | International Journal of Clinical Practice | 2012 | 258 |
22 | Characteristics and healthcare costs of patients with fibromyalgia syndrome | International Journal of Clinical Practice | 2007 | 252 |
23 | The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study | International Journal of Clinical Practice | 2013 | 252 |
24 | The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients | International Journal of Clinical Practice | 2003 | 252 |
25 | Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations | International Journal of Clinical Practice | 2007 | 235 |
26 | The mean platelet volume in patients with obesity | International Journal of Clinical Practice | 2005 | 234 |
27 | Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? | International Journal of Clinical Practice | 2014 | 231 |
28 | Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial | International Journal of Clinical Practice | 2009 | 229 |
29 | Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature | International Journal of Clinical Practice | 2011 | 228 |
30 | One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial | International Journal of Clinical Practice | 2011 | 221 |
31 | Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes | International Journal of Clinical Practice | 2006 | 220 |
32 | Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? | International Journal of Clinical Practice | 2012 | 220 |
33 | The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12 | International Journal of Clinical Practice | 2008 | 216 |
34 | GIDEON (Global Investigation of therapeutic DE cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis | International Journal of Clinical Practice | 2014 | 215 |
35 | Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States | International Journal of Clinical Practice | 2010 | 214 |
36 | Complementary and alternative medicine use in England: results from a national survey | International Journal of Clinical Practice | 2010 | 214 |
37 | Denosumab: mechanism of action and clinical outcomes | International Journal of Clinical Practice | 2012 | 211 |
38 | Patient adherence to medication requirements for therapy of type 2 diabetes | International Journal of Clinical Practice | 2011 | 210 |
39 | The importance of weight management in type 2 diabetes mellitus | International Journal of Clinical Practice | 2014 | 209 |
40 | Pharmacology of phosphodiesterase-5 inhibitors | International Journal of Clinical Practice | 2002 | 206 |
41 | Metabolic side effects of antipsychotic medication | International Journal of Clinical Practice | 2007 | 200 |
42 | Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma | International Journal of Clinical Practice | 2008 | 199 |
43 | Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? | International Journal of Clinical Practice | 2013 | 199 |
44 | Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus | International Journal of Clinical Practice | 2010 | 197 |
45 | Frequency, signs and symptoms, and criteria adopted for long COVID‐19: A systematic review | International Journal of Clinical Practice | 2021 | 197 |
46 | When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed | International Journal of Clinical Practice | 2013 | 193 |
47 | The medicinal use of cannabis in the UK: results of a nationwide survey | International Journal of Clinical Practice | 2004 | 189 |
48 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study | International Journal of Clinical Practice | 2009 | 187 |
49 | Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase III studies | International Journal of Clinical Practice | 2013 | 186 |
50 | Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study | International Journal of Clinical Practice | 2010 | 185 |